ATRA

Insider trade Sale by Grant-Huerta Yanina (Chief Accounting Officer)

12d ago

Insider trade Sale by Nguyen AnhCo (President and CEO)

12d ago

News Biogen (BIIB) to Buy HI-Bio to Expand Rare Disease Pipeline

14d ago

News Atara Biotherapeutics GAAP EPS of -$0.29 misses by $0.04, revenue of $0.52M misses by $1.65M

20d ago

Insider trade Sale by Panacea Innovation Ltd / James Huang

21d ago

Insider trade Purchase by EcoR1 Capital, LLC

21d ago

SEC filing ATRA Press Release: $12M Revenue, $0.05 EPS, +15% YoY, $200M Deal Size

26d ago

SEC filing ATRA Delisted from Nasdaq Global Select Market, $50M MVLS Requirement Missed, 180-Day Compliance Period Until Oct 27 2026, May Seek Capital Market Transfer

31d ago

News Atara Biotherapeutics GAAP EPS of $2.61 beats by $4.06, revenue of $120.8M

77d ago

SEC filing ATRA Reports $120.8M Revenue, $32.7M Net Income, Extends Cash Runway to 2026

77d ago

Scanner Unusual buy pressure (23.1x avg, 62% up-volume, +59.3% / +3.02 intraday, above VWAP)

87d ago

Insider trade Sale by Yanina Grant-Huerta (Chief Accounting Officer)

89d ago

Insider trade Sale by Anhco Nguyen (President and CEO)

89d ago

SEC filing ATRA Amends $9M Milestone Payment to Jan 2028, Issues 400K Warrant at $0.0001 Strike Price

99d ago

Insider trade Sale by Panacea Innovation Ltd / Huang James

104d ago

News Atara plummets on FDA Complete Response Letter for tabelecleucel

141d ago

News Akari Therapeutics Announces $5 Million Financing, Including Concurrent Registered Direct Offering and Private Placement Priced At-Market

168d ago

News Allink Biotherapeutics Completes $47M Extension Rounds of Series A to Accelerate Clinical Programs and Novel Platforms Development

168d ago

News Allink Biotherapeutics Completes $47M Extension Rounds of Series A to Accelerate Clinical Programs and Novel Platforms Development

168d ago